Panchsheel Organics Ltd
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]
- Market Cap ₹ 158 Cr.
- Current Price ₹ 120
- High / Low ₹ 157 / 86.1
- Stock P/E 15.3
- Book Value ₹ 107
- Dividend Yield 2.69 %
- ROCE 10.3 %
- ROE 7.89 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.12 times its book value
Cons
- Company has a low return on equity of 10.3% over last 3 years.
- Dividend payout has been low at 8.28% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 105 | 107 | 107 | 108 | |
| 31 | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 86 | 90 | 93 | 95 | |
| Operating Profit | 5 | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 19 | 18 | 14 | 13 |
| OPM % | 13% | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% | 16% | 13% | 12% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 3 | |
| Interest | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 | 18 | 14 | 14 |
| Tax % | 32% | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | 27% | 24% | 25% | |
| 2 | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | 14 | 11 | 10 | |
| EPS in Rs | 1.90 | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 10.71 | 10.47 | 8.22 | 7.81 |
| Dividend Payout % | 13% | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% | 7% | 8% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 17% |
| 3 Years: | 1% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | -8% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 19% |
| 3 Years: | -16% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 13 | 13 | 13 |
| Reserves | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 84 | 112 | 121 | 128 |
| 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | 5 | 6 | |
| 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 21 | 28 | 24 | 25 | |
| Total Liabilities | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
| 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 14 | 18 | 20 | |
| CWIP | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 15 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 137 | 131 | 135 | |
| Total Assets | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | 1 | 3 | 2 | 5 | 5 | -2 | 0 | 10 | 4 | 10 | |
| -1 | -2 | -2 | -1 | -1 | -2 | -1 | -0 | -34 | -7 | -16 | -7 | |
| 0 | -1 | 1 | -2 | -2 | -1 | -2 | -1 | 36 | 16 | -5 | -4 | |
| Net Cash Flow | 0 | -1 | 0 | -0 | 0 | 1 | 3 | -2 | 1 | 18 | -18 | -1 |
| Free Cash Flow | -0 | -0 | -1 | 2 | 1 | 4 | 3 | -3 | -4 | -0 | -12 | 3 |
| CFO/OP | 46% | 69% | 45% | 79% | 63% | 73% | 85% | 5% | 28% | 82% | 48% | 103% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 | 134 |
| Inventory Days | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 | 211 | 246 | 230 |
| Days Payable | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 | 90 |
| Cash Conversion Cycle | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 | 234 | 276 | 274 |
| Working Capital Days | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 | 203 |
| ROCE % | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 26% | 17% | 14% | 10% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Electricity Consumption per kg of production units/kg |
|
||||||||
| Gas/Furnace Oil Consumption per kg of production liters/kg |
|||||||||
| Total Electricity Consumed units |
|||||||||
| Total Gas/Furnace Oil Consumed liters |
|||||||||
| Export Sales Rs. lakhs |
|||||||||
| Foreign Exchange Earnings Rs. lakhs |
|||||||||
| Number of Permanent Employees employees |
|||||||||
| Manufacturing Area (Constructed) sq.mt |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation-30 Of SEBI (LODR) 2015- Newspaper Publication of Standalone Un-audited Results for quarter ending June, 30 2026 ....
-
Announcement under Regulation 30 (LODR)-Change in Management
- Mrs. Chandan Mahendra Turakhia appointed Additional Director from 14 August 2026, subject to shareholder approval.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Mr. Kishor Abhaychand Turakhia elevated from Whole-time Director to Managing Director, effective 14 August 2026 for five years.
- Board Fixes Record Date For The Purpose Of Distribution Of Interim Dividend For The Quarter Ended June,30 2026
-
Corporate Action-Board approves Dividend
- Board approved Q1 FY27 results, Rs.0.80 interim dividend; record date 21 Aug 2026; new MD appointed.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
POL is a part of Turakhia Bros group. It is a WHO Compliant, ISO and GMP certified manufacturer and exporter of a range of APIs, Intermediates, Nutraceutical, Vitamins Hormones, Steroids, Finished Formulations (Human & Veterinary), Agri Biotech range (Bio Fertilizers, Bio Stimulants,Growth Promoters), Aqua Culture, Dehydrated Culture Media